T Sorahan1, L J Kinlen, R Doll. 1. Institute of Occupational and Environmental Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. T.M.Sorahan@bham.ac.uk
Abstract
AIMS: To examine mortality from different causes and cancer incidence among a cohort of benzene workers in England and Wales. METHODS: A cohort of 5514 workers who had been occupationally exposed to benzene in 1966/67 or earlier was assembled by the former Factory Inspectorate and the Medical Research Council from details provided by 233 employers in England and Wales. The cohort was followed up for mortality (1968-2002) and cancer registrations (1971-2001). National mortality rates and cancer registration (incidence) rates were used to calculate standardised mortality ratios and standardised registration ratios. RESULTS: Mortality was close to expectation for all causes and significantly increased for cancer of the lip, cancer of the lung and bronchus, secondary and unspecified cancers, acute non-lymphocytic leukaemia (ANLL), and all neoplasms. Significant deficits were shown for three non-malignant categories (mental disorders, diseases of the digestive system, accidents). SMRs for other leukaemia, lymphomas, and multiple myeloma were close to or below expectation. There was some evidence of under-ascertainment of cancer registrations, although significantly increased SRRs were shown for lung cancer and cancer of the pleura (mesothelioma). CONCLUSIONS: Many study subjects would have been exposed to carcinogens other than benzene (for example, asbestos, rubber industry fumes, foundry fumes, polycyclic aromatic hydrocarbons), and the excesses of lung cancer and mesothelioma are likely to reflect exposures to these other carcinogens. The carcinogenic effects of benzene exposure on the lymphohaematopoietic system were limited to ANLL.
AIMS: To examine mortality from different causes and cancer incidence among a cohort of benzene workers in England and Wales. METHODS: A cohort of 5514 workers who had been occupationally exposed to benzene in 1966/67 or earlier was assembled by the former Factory Inspectorate and the Medical Research Council from details provided by 233 employers in England and Wales. The cohort was followed up for mortality (1968-2002) and cancer registrations (1971-2001). National mortality rates and cancer registration (incidence) rates were used to calculate standardised mortality ratios and standardised registration ratios. RESULTS: Mortality was close to expectation for all causes and significantly increased for cancer of the lip, cancer of the lung and bronchus, secondary and unspecifiedcancers, acute non-lymphocytic leukaemia (ANLL), and all neoplasms. Significant deficits were shown for three non-malignant categories (mental disorders, diseases of the digestive system, accidents). SMRs for other leukaemia, lymphomas, and multiple myeloma were close to or below expectation. There was some evidence of under-ascertainment of cancer registrations, although significantly increased SRRs were shown for lung cancer and cancer of the pleura (mesothelioma). CONCLUSIONS: Many study subjects would have been exposed to carcinogens other than benzene (for example, asbestos, rubber industry fumes, foundry fumes, polycyclic aromatic hydrocarbons), and the excesses of lung cancer and mesothelioma are likely to reflect exposures to these other carcinogens. The carcinogenic effects of benzene exposure on the lymphohaematopoietic system were limited to ANLL.
Authors: R Doll; M P Vessey; R W Beasley; A R Buckley; E C Fear; R E Fisher; E J Gammon; W Gunn; G O Hughes; K Lee; B Norman-Smith Journal: Br J Ind Med Date: 1972-10
Authors: R B Hayes; S N Yin; M Dosemeci; G L Li; S Wacholder; L B Travis; C Y Li; N Rothman; R N Hoover; M S Linet Journal: J Natl Cancer Inst Date: 1997-07-16 Impact factor: 13.506
Authors: Deborah C Glass; Christopher N Gray; Damien J Jolley; Carl Gibbons; Malcolm R Sim; Lin Fritschi; Geoffrey G Adams; John A Bisby; Richard Manuell Journal: Epidemiology Date: 2003-09 Impact factor: 4.822
Authors: S N Yin; R B Hayes; M S Linet; G L Li; M Dosemeci; L B Travis; C Y Li; Z N Zhang; D G Li; W H Chow; S Wacholder; Y Z Wang; Z L Jiang; T R Dai; W Y Zhang; X J Chao; P Z Ye; Q R Kou; X C Zhang; X F Lin; J F Meng; C Y Ding; J S Zho; W J Blot Journal: Am J Ind Med Date: 1996-03 Impact factor: 2.214
Authors: Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter Journal: Crit Rev Toxicol Date: 2013-02 Impact factor: 5.635
Authors: Jian-Min Yuan; Sharon E Murphy; Irina Stepanov; Renwei Wang; Steven G Carmella; Heather H Nelson; Dorothy Hatsukami; Stephen S Hecht Journal: Cancer Prev Res (Phila) Date: 2016-04-20
Authors: Laura S Gold; Anneclaire J De Roos; Elizabeth E Brown; Qing Lan; Kevin Milliken; Scott Davis; Stephen J Chanock; Yawei Zhang; Richard Severson; Sheila H Zahm; Tongzhang Zheng; Nat Rothman; Dalsu Baris Journal: Cancer Epidemiol Date: 2009-09-06 Impact factor: 2.984